<DOC>
	<DOCNO>NCT02588638</DOCNO>
	<brief_summary>In study , NextGen SE on-hand cohort comprise 50 pediatric 50 adult patient , unclear movement disorder unclear cognitive disorder , examine follow question : Primary : - Number diagnosis make NGS Secondary : 1. restriction quality life unclear disease 2 . Cost purposeful preliminary diagnostics ( beyond minimal diagnostic data set ) 3 . Impact diagnosis therapy follow-up examination 4 . Time diagnosis</brief_summary>
	<brief_title>Next Generation Sequencing Diagnostics - On Road Rapid Diagnostics Rare Diseases</brief_title>
	<detailed_description>In study NextGen SE ( single-center , prospective , open diagnostic study ) on-hand cohort comprise 50 pediatric 50 adult patient , unclear movement disorder unclear cognitive disorder , examine follow question : Primary : - Number diagnosis make next-generation sequencing ( NGS ) Secondary : 1 . Restriction quality life unclear disease 2 . Cost purposeful preliminary diagnostics ( beyond minimal diagnostic data diagnosis therapy follow-up examination 3 . Time diagnosis</detailed_description>
	<mesh_term>Rare Diseases</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<criteria>For patient &gt; 18 year 1 . Unclear movement disorder Progressive ataxia minimal exclusion diagnostics : magnetic resonance tomography ( MRT ) ( structural lesion cerebellar tumor , malformation ) Laboratory ( Vitamin B12 , thyroid peroxidase ( TPO ) antibody , glutamate decarboxylase ( GAD ) IIantibodies ( AK ) In medullary lesion : Liquor exclusion Friedreich ataxia ( FRDA ) spinocerebellar ataxia type ( SCA ) 1236 Progressive paraspasticity minimal exclusion diagnostics : MRT neuro axis ( structural lesion cervical myelopathy ) Laboratory ( Vitamin B12 , human Tcell lymphotrophic virus ( ( HTLV ) AK ) In medullary lesion : Liquor 2 . Unclear cognitive decline After minimal exclusion diagnosis MRT ( intracranial pressure , focal brain lesion explanatory ) laboratory ( Thyroidstimulating hormone ( TSH ) , TPOAK , antibody profile limbic encephalitis ) Liquor ( inflammation , meningitis ) Electroencephalography ( EEG ) ( Status ) Exclusion chromosome 9 open reading frame 72 ( C9orf72 ) For patient &lt; 18 year Patients ( penetrate ) suspect cerebral neurogenetic disease Unclear movement disorder ( spasticity , ataxia , dyskinesia ) Unclear cognitive disorder probability monogenic origin Fragile X Syndrome ( FraX ) mentally retarded boy , Friedreich ataxia ( FRDA ) ataxia genetically exclude For patient &gt; 18 year 1 . Lack consent 2. symptom onset &gt; 40 year age 3 . Sudden , abrupt begin 4 . As early previous history genetic diagnosis use nextgeneration sequencing ( NGS ) , also form panel For patient &lt; 18 year 1. injury brain disorder On basis image On basis medical history ( premature baby , hypoxicischemic encephalopathy ) 2 . Inflammatory brain disorder On basis image On basis laboratory parameter ( Oligoclonal fraction , cerebrospinal fluid ( CSF ) cell count increase ) 3 . Light , isolate mental developmental disorder behavioral disorder ( rare monogenetic ) ( le 2 standard deviartion normal &lt; 6 year old less 1 year development history back ) 4 . Sudden , abrupt begin 5 . Nextgeneration sequence ( NGS ) also form panel</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>NGS</keyword>
	<keyword>Quality life</keyword>
	<keyword>Diagnosis</keyword>
	<keyword>Rare disease</keyword>
	<keyword>Next-generation sequencing</keyword>
</DOC>